Author: Martincic, Ziga; Skopec, Barbara; Rener, Karla; Mavric, Matej; Vovko, Tomaz; Jereb, Matjaz; Lukic, Milica
Title: Severe immune thrombocytopenia in a critically ill COVID-19 patient Cord-id: zrf48yjg Document date: 2020_8_6
ID: zrf48yjg
Snippet: The novel coronavirus SARS-CoV-2 can cause severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19, who developed severe immune thrombocytopenia, which was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins.
Document: The novel coronavirus SARS-CoV-2 can cause severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19, who developed severe immune thrombocytopenia, which was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins.
Search related documents:
Co phrase search for related documents- adaptive immune system and liver renal function: 1
- admission blood test and lopinavir ritonavir: 1
- liver renal and lmwh weight heparin: 1
- liver renal and lopinavir ritonavir: 1, 2, 3, 4, 5
- liver renal and low molecular lmwh weight heparin: 1
- liver renal function and lopinavir ritonavir: 1, 2
- lmwh weight heparin and lopinavir ritonavir: 1, 2, 3
- lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- lopinavir ritonavir and low molecular lmwh weight heparin: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date